Vaccines & Autism
Vaccine efficacy refers to the ability of vaccines to bring about the intended beneficial effects on vaccinated individuals in a defined population under ideal conditions of use. The potential benefits of an effective vaccine – e.g. promotion of health and well-being, and protection from illness and its physical, psychological and socioeconomic consequences must be weighed against the potential risk of an adverse event following immunization (AEFI) with that vaccine. Vaccine-associated risk is the probability of an adverse or unwanted outcome occurring, and the severity of the resulting harm to the health of vaccinated individuals in a defined population following immunization with a vaccine under ideal conditions of use.
Related Conference of Vaccines & Autism
6th World Congress on Neuroimmunology and Neuroinfectious Diseases
13th World Congress and Exhibition on Antibiotics and Antibiotic Resistance
Vaccines & Autism Conference Speakers
Recommended Sessions
- Animal Models & Clinical Trials
- Antibodies: Engineering & Therapeutics
- Cancer, Malaria & TB Vaccines
- Cellular Immunology & Latest Innovations
- Combination & Conjugate Vaccines
- Current Research & Future Challenges
- DNA & Synthetic Vaccines
- Fish & Poultry Vaccines
- Geriatric Immunization
- HIV Vaccines
- Peadiatric Vaccination
- Travel & Edible Vaccines
- Vaccine Production & Development
- Vaccines
- Vaccines & Autism
- Vaccines against Drugs
- Vaccines against Infectious Diseases
- Vaccines for Immune Mediated Diseases
- Vaccines for Pregnant Women & Neonates
- Vaccines for Unconventional Diseases
- Vectors, Adjuvants & Delivery Systems
Related Journals
Are you interested in
- Advances in Immunotherapy for Neuroimmune Disorders - Neuroimmunology Congress 2025 (Netherlands)
- Antibiotic Prophylaxis - Antibiotics 2026 (UK)
- Antibiotic Resistance: Opportunities and Challenges - Antibiotics 2026 (UK)
- Antibiotic-resistant Bacterial infections - Antibiotics 2026 (UK)
- Antibiotics - Antibiotics 2026 (UK)
- Antibiotics for Various Diseases and Infections - Antibiotics 2026 (UK)
- Antibiotics: In Pregnancy and Lactation - Antibiotics 2026 (UK)
- Antimicrobial Peptides - Antibiotics 2026 (UK)
- Antimicrobial Therapy - Antibiotics 2026 (UK)
- Artificial Intelligence in Neuroimmunology Research - Neuroimmunology Congress 2025 (Netherlands)
- Autoimmunity in Neurodegenerative Diseases - Neuroimmunology Congress 2025 (Netherlands)
- Cancer Immunology and Immunotherapy - European Immunology 2025 (Italy)
- Cellular and Molecular Immunotherapy in Neuroinfectious Diseases - Neuroimmunology Congress 2025 (Netherlands)
- Clinical Trials of Antibiotics - Antibiotics 2026 (UK)
- Current Research in Antibiotic Resistance - Antibiotics 2026 (UK)
- Developing Alternatives to Antibiotics - Antibiotics 2026 (UK)
- Diagnostic and Technological Novelty of Immunology - European Immunology 2025 (Italy)
- Drug Discovery and Novel Delivery Technologies - Antibiotics 2026 (UK)
- Emerging Viral Neuroinfections - Neuroimmunology Congress 2025 (Netherlands)
- Epidemiology - European Immunology 2025 (Italy)
- Gene Editing and Neuroimmune Disorders - Neuroimmunology Congress 2025 (Netherlands)
- Genomics and Precision Medicine in Neuroimmunology - Neuroimmunology Congress 2025 (Netherlands)
- Immune System - European Immunology 2025 (Italy)
- Immunodeficiency - European Immunology 2025 (Italy)
- Immunogenetics - European Immunology 2025 (Italy)
- Immunoinformatics & Systems Immunology - European Immunology 2025 (Italy)
- Immunological Techniques - European Immunology 2025 (Italy)
- Immunology - European Immunology 2025 (Italy)
- Immunology & Vaccines - Antibiotics 2026 (UK)
- Immunometabolism in Neuroinflammation - Neuroimmunology Congress 2025 (Netherlands)
- Immunotherapy - European Immunology 2025 (Italy)
- Immunotoxicology - European Immunology 2025 (Italy)
- Infectious Diseases - Antibiotics 2026 (UK)
- Innate Immunity in Neurological Diseases - Neuroimmunology Congress 2025 (Netherlands)
- Mechanisms and Evolution of Antibiotic Resistance - Antibiotics 2026 (UK)
- Micro Organisms in Recent Drug Discovery - Antibiotics 2026 (UK)
- Microorganisms Producing Antibiotics - Antibiotics 2026 (UK)
- Modern Antibiotics for Various Diseases and Infections - Antibiotics 2026 (UK)
- Molecular Pathways in Neuroimmune Disorders - Neuroimmunology Congress 2025 (Netherlands)
- Neuroimmune Biomarkers: From Discovery to Clinical Application - Neuroimmunology Congress 2025 (Netherlands)
- Neuroimmune Mechanisms in CNS Infections - Neuroimmunology Congress 2025 (Netherlands)
- Neuroimmune Responses to Environmental Triggers - Neuroimmunology Congress 2025 (Netherlands)
- Neuroimmunology - European Immunology 2025 (Italy)
- Neuroimmunology of Aging and Neurodegeneration - Neuroimmunology Congress 2025 (Netherlands)
- Neuroimmunology of Pain and Neuropathic Conditions - Neuroimmunology Congress 2025 (Netherlands)
- Neuroinfectious Disease Epidemiology - Neuroimmunology Congress 2025 (Netherlands)
- Neuroinflammation and Psychiatric Disorders - Neuroimmunology Congress 2025 (Netherlands)
- New antibiotics and non-antibiotic approaches - Antibiotics 2026 (UK)
- Parasite Immunology - European Immunology 2025 (Italy)
- Pediatrics Immunology - European Immunology 2025 (Italy)
- Pharmacokinetics and Pharmacodynamics of Antimicrobial Drugs - Antibiotics 2026 (UK)
- Pharmacology & Toxicology - Antibiotics 2026 (UK)
- Prevention and Control of Antibiotic Resistance - Antibiotics 2026 (UK)
- Reproductive Immunology - European Immunology 2025 (Italy)
- Role of Microglia in Neuroimmunology - Neuroimmunology Congress 2025 (Netherlands)
- The Blood-Brain Barrier in Health and Disease - Neuroimmunology Congress 2025 (Netherlands)
- The Microbiome-Neuroimmune Connection - Neuroimmunology Congress 2025 (Netherlands)
- The Next Generation Approach of Antibiotics - Antibiotics 2026 (UK)
- Transplantation Immunology - European Immunology 2025 (Italy)
- Viral Immunology - European Immunology 2025 (Italy)